JPRN-UMIN000002964已完成4 期
Prospective, randomized, open-label, clinical trial comparing fibrate monotherapy and fibrate-ezetimibe combination therapy on progression of atherosclerotic plaques, endothelial function, and markers for anti-inflammatory properties/obesity/antioxidative properties - Prospective, randomized, open-label, clinical trial comparing fibrate monotherapy and fibrate-ezetimibe combination therapy
ational Defense Medical College0 个研究点目标入组 60 人开始时间: 2010年1月3日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Allergy against ezetimibe 2) Under treatment with statins 3) Poor-controlled hypertension (DBP>110 mmHg) 4) Poor-controlled diabetes (HbA1c>10.0 %) 5) History of stroke, acute coronary syndrome or any cardiovascular diseases needed for inpatient-treatments within 6 months 6) Either level of aspartate aminotransaminase or alanine aminotransferase exceeds three-fold of the normal limits. 7) Chronic renal failure (serum creatinine>2.0 mg/dl) 8) Malignancies or other diseases with poor prognosis 9) Pregnant 10) Subjects whose doctor in charge do not agree to join the trial
研究者
相似试验
已完成
不适用
Prospective, randomized, open-label, clinical trial evaluating the effects of dipeptidyl peptidase-4 (DPP4) inhibitors on progression of atherosclerotic plaques and endothelial function in type 2 diabetic patientstype 2 diabetesJPRN-UMIN000011752ational Defense Medical College66
已完成
4 期
Prospective, randomized, open-label, clinical trial evaluating the effects of pioglitazone on progression of atherosclerotic plaques, endothelial function, and markers for anti-inflammatory properties/obesity/antioxidative propertiesdiabetesJPRN-UMIN000002963ational Defense Medical College60
已完成
不适用
Prospective, randomized, open-label, clinical trial comparing rosuvastatin monotherapy and combination therapy with ezetimibe on progression of atherosclerotic plaques and endothelial functioDyslipidemiaJPRN-UMIN000011745ational Defense Medical College66
已完成
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of bezafibrate and ethyl icosapentate/docosahexaenoate combination on progression of atherosclerotic plaques, endothelial function and markers for inflammatiodyslipidemiaJPRN-UMIN000012267ational Defense Medical College66
已完成
4 期
Prospective, randomized, open-label, clinical trial comparing the different Sufonyl Urea(SU) combination with DPP4 inhibitorDiabetes MellitusJPRN-UMIN000003006Kobe University Hospital80